Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant (2022)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROSSI, GIORDANO NOVAK - FMRP ; GUERRA, LORENA TERENE LOPES - FMRP
- Unidade: FMRP
- DOI: 10.3390/biom12111618
- Subjects: ALCALOIDES; ANTIDEPRESSIVOS; ALUCINOGÊNICOS; PLANTAS ALUCINÓGENAS
- Keywords: Ayahuasca; Antidepressant; Psychedelic
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Biomolecules
- ISSN: 2218-273X
- Volume/Número/Paginação/Ano: v. 12, n. 11, art. 1618, p. 1-24, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ROSSI, Giordano Novak et al. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, v. 12, n. 11, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12111618. Acesso em: 30 set. 2024. -
APA
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Saiz, J. C. B., Hallak, J. E. C., & Santos, R. G. dos. (2022). Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, 12( 11), 1-24. doi:10.3390/biom12111618 -
NLM
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/biom12111618 -
Vancouver
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/biom12111618 - Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview
- Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Adverse effects after Ayahuasca administration in the clinical setting [Carta]
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
Informações sobre o DOI: 10.3390/biom12111618 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas